Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Chief Financial Officer sold 445 shares at $14.49 ($6,448)
  3. 4 Open-market sale President, R&D sold 980 shares at $14.49 ($14,200)
  4. 4 Open-market sale Chief Legal Officer sold 295 shares at $14.49 ($4,275)
  5. 4 Open-market sale President and CEO sold 42,000 shares at an average $20.06 ($842,520)
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Open-market sale Chief Administrative Officer sold 448 shares at $21.54 ($9,650)
  9. 4 Open-market sale Chief Financial Officer sold 1,099 shares at $21.54 ($23,672)
  10. 4 Open-market sale President, R&D sold 9,817 shares at an average $22.53 ($221,138)
  11. 4 Open-market sale Chief Legal Officer sold 728 shares at $21.54 ($15,681)
  12. 4 Open-market sale President and CEO sold 42,000 shares at an average $21.04 ($883,680)
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 4 Open-market sale President, R&D sold 8,000 shares at $22.43 ($179,440)
  15. 4 Open-market sale Chief Administrative Officer sold 259 shares at $22.73 ($5,887)
  16. 4 Open-market sale Chief Financial Officer sold 443 shares at $22.73 ($10,069)
  17. 4 Open-market sale President, R&D sold 976 shares at $22.73 ($22,184)
  18. 4 Open-market sale Chief Legal Officer sold 294 shares at $22.73 ($6,683)
  19. 4 Open-market sale President and CEO sold 42,000 shares at an average $24.24 ($1,018,080)
  20. 8-K Event Material agreement · Other events

Page 18 of 28 · 556 filings